Through the above experiments, we concluded that tRF‐34‐P4R8YP9LON4VHM could promote the progression of HCC by directly targeting DAB2IP 3′‐UTR and silencing its expression. The gene discussed is DAB2IP; the disease is hepatocellular carcinoma.